Gwen A. Melincoff

Director, Tobira Therapeutics, Inc.

Companies

Chemomab Therapeutics Ltd.Board member Jun 3, 2026 to now¹
Gain Therapeutics, Inc.Board member Mar 17, 2021 to now²
Protalix Biotherapeutics IncBoard member Jan 3, 2020 to now³
COLLEGIUM PHARMACEUTICAL, INCBoard member Aug 11, 2017 to May 16, 2024⁴
SOLENO THERAPEUTICS INCBoard member Apr 29, 2019 to May 26, 2023⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

COLLEGIUM PHARMACEUTICAL, INC COLL52,468 shares⁶$1.2M at $23.45May 16, 2024
Protalix Biotherapeutics Inc PLX7,500 shares⁷$20.4K at $2.71Sep 3, 2025
SOLENO THERAPEUTICS INC666 shares⁸Oct 14, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 3, 2025Granted 7,500 shares of Protalix Biotherapeutics Inc⁷
May 16, 2024Granted 7,693 shares of COLLEGIUM PHARMACEUTICAL, INC⁶
May 18, 2023Granted 9,792 shares of COLLEGIUM PHARMACEUTICAL, INC⁹
May 19, 2022Granted 14,035 shares of COLLEGIUM PHARMACEUTICAL, INC¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARChemomab Therapeutics Ltd., Board member
2
SEC EDGARGain Therapeutics, Inc., Board member
3
SEC EDGARProtalix Biotherapeutics Inc, Board member
4
SEC EDGARCOLLEGIUM PHARMACEUTICAL, INC, Board member
5
SEC EDGARSOLENO THERAPEUTICS INC, Board member
6
SEC EDGARCOLLEGIUM PHARMACEUTICAL, INC shares after the filing of May 16, 2024
7
SEC EDGARProtalix Biotherapeutics Inc shares after the filing of Sep 3, 2025
8
SEC EDGARSOLENO THERAPEUTICS INC shares after the filing of Oct 14, 2022
9
SEC EDGARForm 4 filed May 19, 2023
10
SEC EDGARForm 4 filed May 23, 2022